3D Bioprinting: use of Polycaprolactone in clinical and research biomedical applications

duo presentation by

Andrea Del Fattore, Head of the Bone Physiopathology Group, Bambino Gesù Children’s Hospital, Rome, Italy

& Luca Borro, 3D Specialist, 3D Biomedica Advanced Modeling and Printing Technician, Bambino Gesù Children’s Hospital, Rome, Italy

Bioprinting is a technology that could revolutionize the biomedical field. It has already been used to engineer constructs that mimic aspects of the anatomical and structural complexity, allowing the production of perfectly functional and “biologically active” patient-specific parts.

One of the most important challenges of bioprinting is the identification of biomaterials that have adequate biocompatibility and biodegradability features to be used in clinical use in humans.

In this session we will describe some applications of 3D Bioprinting of Polycaprolactone in clinical applications and in research contexts.

We will show how Polycaprolactone can be used to 3D Bioprint patient-specific tracheal splints for the treatment of severe tracheo-bronchomalacias and we will present some preliminary results on the use of this material in bone regeneration research.

program: https://3dmedicalconference.com/program/


Why should the delegate attend your presentation?
To learn the future directions of bone regeneration

What emerging technologies/trends do you see as having the greatest potential in the short and long run?
3D bioprinting of organs

What kind of impact do you expect them to have?
To face the problems regarding organ donation and rejection

About Bambino Gesù Children’s Hospital

The Bambino Gesù Paediatric Hospital (OPBG) is a Scientific Institute for Research, Hospitalization and Health Care, Italy’s main paediatric Hospital providing advanced health care for children and performing basic, clinical and translational research activities.

With its 11 Departments, covering all aspects of paediatrics care, the Hospital provides a complete range of healthcare services to children. OPBG has a total permanent staff of aprox 2,500, of which 625 physicians and biologists, involved both in clinical and in research activities. There are also aprox 50 post-graduate trainees (medical and surgical) and over 100 students and interns. Yearly clinical activities consist of aprox 27,000 inpatient admissions, 77,000 day hospital admissions, 6,000 day surgery treatments and over 1,500,000 outpatient visits. The Hospital’s clinical activities run side by side with its scientific research, aiming at constantly improving and innovating diagnostic and therapeutic procedures.

Leave a Reply

Your email address will not be published.